Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release Article

Encinas-Basurto, David, Konhilas, John P, Polt, Robin et al. (2022). Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release . 14(3), 10.3390/pharmaceutics14030587

Open Access

cited authors

  • Encinas-Basurto, David; Konhilas, John P; Polt, Robin; Hay, Meredith; Mansour, Heidi M

sustainable development goals

authors

publication date

  • March 1, 2022

webpage

keywords

  • AXIS
  • DRUG-DELIVERY
  • HEART-FAILURE
  • Life Sciences & Biomedicine
  • MICROSPHERES
  • PLGA diblock copolymer
  • PNA5 glycopeptide
  • PROTEIN
  • Pharmacology & Pharmacy
  • Science & Technology
  • TECHNOLOGIES
  • angiotensin
  • biocompatible
  • biodegradable
  • cardiovascular
  • double emulsion solvent evaporation
  • ester and acid-end capped
  • mas receptor
  • neurodegenerative diseases

Digital Object Identifier (DOI)

publisher

  • MDPI

volume

  • 14

issue

  • 3